MS
76
2
RCL
64
-2
TRIP
54
2
NTAP
73
2
MPC
41
-3
NAVI
43
2
BLK
60
3
WMB
59
3
MSFT
70
8
GWW
60
7
CCL
41
-2
DVA
75
2
CSX
44
-4
HBAN
56
2
VFC
33
4
MOS
36
4
AEP
59
-3
EFX
77
3
KIM
57
3
HES
71
-3
MS
76
2
RCL
64
-2
TRIP
54
2
NTAP
73
2
MPC
41
-3
NAVI
43
2
BLK
60
3
WMB
59
3
MSFT
70
8
GWW
60
7
CCL
41
-2
DVA
75
2
CSX
44
-4
HBAN
56
2
VFC
33
4
MOS
36
4
AEP
59
-3
EFX
77
3
KIM
57
3
HES
71
-3
Financhill
Back

Globus Medical 10K Form

Buy
61

GMED
Globus Medical

Last Price:
62.86
Seasonality Move:
3.48%

7 Day Trial

ALL ACCESS PASS

$ 7

Key Filings

2024-05-07 10Q GMED/Globus Medical Quarterly
2023-11-07 10Q GMED/Globus Medical Quarterly
2023-08-03 10Q GMED/Globus Medical Quarterly
2023-05-04 10Q GMED/Globus Medical Quarterly
2022-11-08 10Q GMED/Globus Medical Quarterly
2022-08-04 10Q GMED/Globus Medical Quarterly

Receive GMED News And Ratings

See the #1 stock for the next 7 days that we like better than GMED

GMED Financial Statistics

Sales & Book Value

Annual Sales: $1.57B
Cash Flow: $23.82M
Price / Cash Flow: 50.78
Annual Sales: $29.04
Price / Book: 2.16

Profitability

EPS (TTM): 0.64000
Net Income (TTM): $66.63M
Gross Margin: $1.02B
Return on Equity: 2.08%
Return on Assets: 1.69%

Globus Medical Earnings Forecast

Key Globus Medical Financial Ratios

  • The Gross Profit Margin over the past 15 years for GMED is 65.05%.
  • The Selling, General & Administrative Expenses for GMED have been equal to 41.02% of Gross Profit Margin.
  • The Research & Development expenses have been 7.91% of Revenue.
  • The Interest Expense is -11.22% of Operating Income.
  • The Net Earning history of GMED is 7.83% of Total Revenues.
  • Per Share Earnings over the last 15 years have been positive in 8 years.

Globus Medical Stock Price Chart

Industry, Sector and Symbol

Stock Exchange: NYSE
Industry: Health Care Equipment & Supplies
Sector: Health Care
Current Symbol: GMED
CUSIP: 379577
Website: globusmedical.com

Debt

Debt-to-Equity Ratio: 0.11
Current Ratio: 2.33
Quick Ratio: 1.23

Price-to-Earnings

Trailing P/E Ratio: 58.73
Forward P/E Ratio: 18.99

GMED Technical Analysis vs Fundamental Analysis

Buy
61
Globus Medical (GMED) is a Buy

Is Globus Medical a Buy or a Sell?

  • Globus Medical stock is rated a Buy
    The current Globus Medical [GMED] share price is $62.84. The Score for GMED is 61, which is 22% above its historic median score of 50, and infers lower risk than normal.